Application value of placental growth factor，soluble fms-like tyrosine kinase-1，and glycosylated fibronectin in the prediction of preeclampsia

Yang Lan; Xiao Jianping; Shi Hao; Su Jingna; Zhao Di; Zhao Li; Tang Ye

doi:10.13406/j.cnki.cyxb.003412

您当前的位置：

首页 >

文章列表页 >

Application value of placental growth factor，soluble fms-like tyrosine kinase-1，and glycosylated fibronectin in the prediction of preeclampsia

Clinical research | 更新时间：2025-12-29

- Application value of placental growth factor，soluble fms-like tyrosine kinase-1，and glycosylated fibronectin in the prediction of preeclampsia
- Journal of Chongqing Medical University Vol. 49, Issue 1, Pages: 50-54(2024)
- 作者机构：
  
  无锡市妇幼保健院医学遗传与产前诊断科，无锡 214002
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.003412
  CLC： R71
- Received：06 March 2023，
  
  Revised：2023-05-24，
  
  Accepted：20 June 2023，
  
  Published：28 January 2024
- 稿件说明：
移动端阅览
杨岚,肖建平,石皓,等.胎盘生长因子、可溶性fms样酪氨酸激酶-1及糖基化纤连蛋白在子痫前期预测中的应用价值[J].重庆医科大学学报,2024,49(1):50-54.

Yang Lan,Xiao Jianping,Shi Hao,et al.Application value of placental growth factor，soluble fms-like tyrosine kinase-1，and glycosylated fibronectin in the prediction of preeclampsia[J].Journal of Chongqing Medical University,2024,49(1):50-54.
杨岚,肖建平,石皓,等.胎盘生长因子、可溶性fms样酪氨酸激酶-1及糖基化纤连蛋白在子痫前期预测中的应用价值[J].重庆医科大学学报,2024,49(1):50-54. DOI： 10.13406/j.cnki.cyxb.003412.

Yang Lan,Xiao Jianping,Shi Hao,et al.Application value of placental growth factor，soluble fms-like tyrosine kinase-1，and glycosylated fibronectin in the prediction of preeclampsia[J].Journal of Chongqing Medical University,2024,49(1):50-54. DOI： 10.13406/j.cnki.cyxb.003412.

摘要

目的

探讨胎盘生长因子（placental growth factor，PLGF）、可溶性fms样酪氨酸激酶-1（soluble fms-like tyrosine kinase-1，SFLT-1）和糖基化纤连蛋白（glycosylated fibronectin，GLYFN）检测对子痫前期的预测价值。

方法

选择在无锡市妇幼保健院就诊的188例孕妇，分154例正常孕妇（对照组）和34例子痫前期患者（子痫组），应用免疫荧光法分别检测其在孕16~18周血清中PLGF、SFLT-1和GLYFN的浓度，比较子痫前期组和对照组各标志物的水平，并使用受试者操作特征曲线（receiver operating characteristic，ROC）对3种标志物的预测价值进行效能评估。

结果

在妊娠中期，子痫前期组血清PLGF浓度低于对照组，SFLT-1及GLYFN浓度均高于对照组，3种标志物的差异均有统计学意义（3指标

=0.000）。95%置信区间的ROC曲线下面积（areas under the ROC curve，AUC）为，PLGF为0.941（0.907~0.974），SFLT-1为0.881（0.800~0.962），GLYFN为0.951（0.918~0.985），联合指标SFLT-1和GLYFN、3项指标联合检测在ROC曲线下面积（areas under the ROC curve，AUC）分别为0.968、0.986。

结论

PLGF、SFLT-1、GLYFN 3种标志物水平在对照组和子痫前期组均存在明显差异，对子痫前期的发病具有一定的预测价值，SFLT-1联合PLGF、SFLT-1联合GLYFN、3项指标联合检测对子痫前期的预测价值高于任一单项指标。

Abstract

Objective

To explore the value of placental growth factor（PLGF），soluble fms-like tyrosine kinase-1（SFLT-1），and glycosylated fibronectin（GLYFN） in predicting preeclampsia.

Methods

A total of 188 pregnant women who visited Wuxi Maternal and Child Health Hospital were enrolled in the study and divided into control group（154 normal pregnant women） and preeclampsia group（34 patients with preeclampsia）. The concentrations of serum PLGF，SFLT-1，and GLYFN at the 16th to 18th weeks of gestation were measured by immunofluorescence assay. The levels of individual markers were compared between the preeclampsia group and the control group. The receiver operating characteristic（ROC） curves were used to assess the efficiency of the three markers in terms of predictive value.

Results

During the mid-pregnancy period，the preeclampsia group had a significantly lower concentration of serum PLGF but significantly higher concentrations of serum SFLT-1 and GLYFN compared with the control group（all

=0.000）. The areas under the ROC curve（AUC） for the 95% confidence interval were 0.941（0.907-0.974），0.881（0.800-0.962），and 0.951（0.918-0.985） for PLGF，SFLT-1，and GLYFN，respectively. The AUCs for SFLT-1 combined with GLYFN and the combined detection of t

he three indices were 0.968 and 0.986，respectively.

Conclusion

There are significant differences between the control group and the preeclampsia group in the marker levels of serum PLGF，SFLT-1，and GLYFN，which has some value in predicting the onset of preeclampsia. The predictive value of SFLT-1 combined with PLGF，SFLT-1 combined with GLYFN，and the combination of the three markers are greater than that of any single index.

关键词

Keywords

references

曹泽毅 . 中华妇产科学 [M ] . 2版 . 北京：人民卫生出版社， 2004 ： 39 .

Cao ZY . Chinese obstetrics and gynecology [M ] . 2nd ed . Beijing ： People’s Medical Publishing House ， 2004 ： 39 .

Duhig K ， Vandermolen B ， Shennan A . Recent advances in the diagnosis and management of pre-eclampsia [J ] . F1000Res ， 2018 ， 7 ： 242 .

Cirillo PM ， Cohn BA . Pregnancy complications and cardiovascular disease death：50-year follow-up of the Child Health and Development Studies pregnancy cohort [J ] . Circulation ， 2015 ， 132 （ 13 ）： 1234 - 1242 .

Ives CW ， Sinkey R ， Rajapreyar I ， et al . Preeclampsia-patho-physiology and clinical presentations：JACC state-of-the-art review [J ] . J Am Coll Cardiol ， 2020 ， 76 （ 14 ）： 1690 - 1702 .

Gestational hypertension and preeclampsia：ACOG practice bulletin，number 222 [J ] . Obstet Gynecol ， 2020 ， 135 （ 6 ）： e237 - e260 .

Waugh J ， Bell SC ， Kilby MD ， et al . Urine protein estimation in hypertensive pregnancy：which thresholds and laboratory assay best predict clinical outcome? [J ] . Hypertens Pregnancy ， 2005 ， 24 （ 3 ）： 291 - 302 .

孙文静，胡孟彩，崔世红，等 . 妊娠相关血浆蛋白A、胎盘生长因子联合胆红素对子痫前期的预测价值 [J ] . 中外医学研究， 2021 ， 19 （ 4 ）： 74 - 77 .

Sun WJ ， Hu MC ， Cui SH ， et al . Predictive value of PAPP-A，PLGF and bilirubin in preeclampsia [J ] . Chin Foreign Med Res ， 2021 ， 19 （ 4 ）： 74 - 77 .

Zeisler H ， Llurba E ， Chantraine F ， et al . Predictive value of the sFlt-1：PlGF ratio in women with suspected preeclampsia [J ] . N Engl J Med ， 2016 ， 374 （ 1 ）： 13 - 22 .

Hypertension in pregnancy . report of the American college of obstetricians and gynecologists’ task force on hypertension in pregnancy [J ] . Obstet Gynecol ， 2013 ， 122 （ 5 ）： 1122 - 1131 .

Phipps E ， Prasanna D ， Brima W ， et al . Preeclampsia：updates in pathogenesis，definitions，and guidelines [J ] . Clin J Am Soc Nephrol ， 2016 ， 11 （ 6 ）： 1102 - 1113 .

Brown MA ， Magee LA ， Kenny LC ， et al . The hypertensive disorders of pregnancy：ISSHP classification，diagnosis & management recommendations for international practice [J ] . Pregnancy Hypertens ， 2018 ， 13 ： 291 - 310 .

Liu N ， Guo YN ， Gong LK ， et al . Advances in biomarker development and potential application for preeclampsia based on pathogenesis [J ] . Eur J Obstet Gynecol Reprod Biol X ， 2021 ， 9 ： 100119 .

Kuupiel D ， Bawontuo V ， Mashamba-Thompson TP . Improving the accessibility and efficiency of point-of-care diagnostics services in low- and middle-income countries：lean and agile supply chain management [J ] . Diagnostics ， 2017 ， 7 （ 4 ）： 58 .

Wang P ， Kricka LJ . Current and emerging trends in point-of-care technology and strategies for clinical validation and implementation [J ] . Clin Chem ， 2018 ， 64 （ 10 ）： 1439 - 1452 .

Zhao MT ， Zhu ZQ ， Liu CD ， et al . Dual-cutoff of sFlt-1/PlGF ratio in the stratification of preeclampsia：a systematic review and meta-analysis [J ] . Arch Gynecol Obstet ， 2017 ， 295 （ 5 ）： 1079 - 1087 .

常梓殷，沈　琦，杨小风，等 . 胎盘生长因子水平联合唐氏筛查结果预测子痫前期的价值 [J ] . 医药论坛杂志， 2021 ， 42 （ 23 ）： 7 - 10，17 .

Chang ZY ， Shen Q ， Yang XF ， et al . Value of concentration of PLGF combined with Down’s screening results in predicting preeclampsia [J ] . J Med Forum ， 2021 ， 42 （ 23 ）： 7 - 10，17 .

邱德稳，钟　师，曾辛 . 血脂指标与胎盘生长因子联合检测对子痫前期的诊断价值 [J ] . 检验医学与临床， 2021 ， 18 （ 6 ）： 781 - 784 .

Qiu DW ， Zhong S ， Zeng X . The diagnostic value of combined detection of blood lipid indexes and placental growth factor for preeclampsia [J ] . Lab Med Clin ， 2021 ， 18 （ 6 ）： 781 - 784 .

Fillion A ， Guerby P ， Lachance C ， et al . Placental growth factor and soluble，fms-like tyrosine kinase-1 in preeclampsia：a case-cohort（PEARL） study [J ] . J D'obstetrique Gynecol Du Can ， 2020 ， 42 （ 10 ）： 1235 - 1242 .

马锦琪，李　鹰，黄建荣，等 . 胎盘生长因子荧光免疫层析法检测的临床性能评估 [J ] . 南京医科大学学报（自然科学版）， 2021 ， 41 （ 1 ）： 54 - 58，64 .

Ma JQ ， Li Y ， Huang JR ， et al . Performance evaluation of placental growth factor by fluorescence immunochromatography [J ] . J Nanjing Med Univ Nat Sci ， 2021 ， 41 （ 1 ）： 54 - 58，64 .

Nagalla SR ， Janaki V ， Vijayalakshmi AR ， et al . Glycosylated fibronectin point-of-care test for diagnosis of pre-eclampsia in a low-resource setting：a prospective Southeast Asian population study [J ] . BJOG ， 2020 ， 127 （ 13 ）： 1687 - 1694 .

DiPrisco B ， Kumar A ， Kalra B ， et al . Glycosylated fibronectin and inhibin are lower and anti-müllerian hormone is higher in umbilical cord blood when mothers have preeclampsia [J ] . Endocr Pract ， 2020 ， 26 （ 3 ）： 318 - 327 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Lactate dehydrogenase: a potential regulatory molecule in preeclampsia

Study on the diagnostic value of inflammation score system in preeclampsia

Related Author

Gu Weirong

Zhang Xiaoyue

Pei Jiangnan

Liu Zhenzhen

Zhao Keyong

Cai Yu

Qi Hongbo

Chen Wei

Related Institution

Department of Obstetrics，Obstetrics & Gynecology Hospital of Fudan University

Department of Obstetrics and Gynecology，Third Affiliated Hospital of Zunyi Medical University， Zunyi First People’s Hospital

Department of Emergency & Intensive Care Units,The First Affiliated Hospital of Chongqing Medical University

Department of Obstetrics and Gynecology,The First Affiliated Hospital of Chongqing Medical University

Department of Obstetrics and Gynecology,Chengdu Women’s and Children’s Central Hospital

⁰